Whitfield Dianne C. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) CHRO Dianne C. Whitfield Sells 12,274 Shares
What Happened
Dianne C. Whitfield, Chief Human Resources Officer of Tarsus Pharmaceuticals (TARS), reported three open-market/private sales (code S) tied to the settlement of restricted stock units. She sold 4,029 shares on 2026-03-17 at $69.42 for $279,693; 4,071 shares on 2026-03-18 at $68.71 for $279,718; and 4,174 shares on 2026-03-19 at $67.00 for $279,658 — a total of 12,274 shares and $839,069 in proceeds. These were sell-to-cover transactions to satisfy tax withholding obligations, not discretionary investment sales.
Key Details
- Transaction dates and prices:
- 2026-03-17 — 4,029 shares @ $69.42 ($279,693)
- 2026-03-18 — 4,071 shares @ $68.71 ($279,718)
- 2026-03-19 — 4,174 shares @ $67.00 ($279,658)
- Total: 12,274 shares; total proceeds $839,069; weighted average price ≈ $68.34/share.
- Shares owned after the transactions: Not disclosed in the provided Form 4 details.
- Footnote: F1 — sales were "sell-to-cover" mandated by the issuer to fund tax withholding on RSU vesting/settlement (not discretionary trades by the insider).
- Timeliness: Filed 2026-03-19 for transactions from 2026-03-17–03-19; filing appears timely under Form 4 rules.
Context
Sell-to-cover transactions are common when restricted stock units vest: the company (or broker) sells enough shares to cover the employee’s tax bill. Such sales are administrative and generally should not be interpreted as a personal bearish signal from the insider.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-17$69.42/sh−4,029$279,693→ 43,273 total - Sale
Common Stock
[F1]2026-03-18$68.71/sh−4,071$279,718→ 39,202 total - Sale
Common Stock
[F1]2026-03-19$67.00/sh−4,174$279,658→ 35,028 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.